Papers
1
Total Citations
37
H-Index
1
About
Dr. Jiayi Song is a pioneering researcher at the forefront of biomedical engineering and nanotheranostics, with a primary focus on developing next-generation phototherapy platforms for cancer treatment. Her most-cited work, the 2025 paper on "Aggregation induced emission luminogen bacteria hybrid bionic robot for multimodal phototheranostics and immunotherapy," has already garnered 37 citations, reflecting its immediate impact. Dr. Song's major contribution lies in engineering a novel hybrid system that combines aggregation-induced emission luminogens (AIEgens) with living bacteria to create bionic robots capable of multimodal phototheranostics. This innovative approach overcomes the limitations of conventional photosensitizers—such as single-mechanism action and poor tumor penetration—by enabling simultaneous photodynamic and photothermal therapy, coupled with immunotherapy. Her work represents a paradigm shift toward "one-and-done" cancer treatment strategies, integrating diagnosis and therapy in a single, dynamic platform. By leveraging the natural tumor-targeting ability of bacteria and the superior photophysical properties of AIEgens, Dr. Song has opened new avenues for synergistic cancer therapy. Her research is widely recognized for its translational potential, and she continues to push boundaries in smart biomaterials and immuno-oncology, making her a rising star in the field.
Research Focus
Key Achievements
Top Papers
- 1